Askbio UK Ltd

Research and experimental development on biotechnology · Midlothian

ActiveUnited KingdomIncorporated 2010Private Limited Company

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 282 source facts · 26 selected values

Not assessed

legacy record

Reporting period: 2025-01-01 to 2025-12-31
Extraction status: Legacy / not assessed
Numeric facts: 184
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2025-01-01.xsd
Currency: GBP
Source identifier: Prod223_4252_SC384375_20251231
Source archive: Accounts_Bulk_Data-2026-06-30.zip

Accounts to 2025-12-31

IXBRL · 282 source facts · 26 selected values

Not assessed

legacy record

Reporting period: 2025-01-01 to 2025-12-31
Extraction status: Legacy / not assessed
Numeric facts: 184
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2025-01-01.xsd
Currency: GBP
Source identifier: Prod224_2606_SC384375_20251231
Source archive: Accounts_Monthly_Data-June2026.zip

Accounts to 2024-12-31

IXBRL · 279 source facts · 24 selected values

Not assessed

legacy record

Reporting period: 2024-01-01 to 2024-12-31
Extraction status: Legacy / not assessed
Numeric facts: 180
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2024-01-01.xsd
Currency: GBP
Source identifier: Prod224_2506_SC384375_20241231
Source archive: Accounts_Monthly_Data-June2025.zip

Accounts to 2023-12-31

IXBRL · 301 source facts · 27 selected values

Not assessed

legacy record

Reporting period: 2023-01-01 to 2023-12-31
Extraction status: Legacy / not assessed
Numeric facts: 204
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2023-01-01.xsd
Currency: GBP
Source identifier: Prod224_3000_SC384375_20231231
Source archive: Accounts_Monthly_Data-October2024.zip

Accounts to 2012-08-31

IXBRL · 62 source facts · 18 selected values

Not assessed

legacy record

Reporting period: 2011-09-01 to 2012-08-31
Extraction status: Legacy / not assessed
Numeric facts: 41
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-main-2009-09-01.xsd
Currency: GBP
Source identifier: Prod224_9990_SC384375_20120831
Source archive: Accounts_Monthly_Data-May2013.zip

Accounts to 2011-08-31

XBRL · 30 source facts · 7 selected values

Not assessed

legacy record

Reporting period: — to —
Extraction status: Legacy / not assessed
Numeric facts: 15
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: uk-gaap-ae-2008-04-06.xsd
Currency: GBP
Source identifier: Prod224_9978_SC384375_20110831
Source archive: Accounts_Monthly_Data-May2012.zip

Registered details

SC384375

Status: Active
Type: Private Limited Company
Incorporated: 2010-08-27
Jurisdiction: —
Registered office: 3ROSLIN INNOVATION CENTRE, EASTER BUSH CAMPUS, MIDLOTHIAN, EH25 9RG, SCOTLAND

Classification

1 SIC codes

72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

1 SH01-derived rounds

2021-12-23

£2,951,000 raised

£6,119,144 estimated post-money

Research and innovation

7 matched grants

Development of a novel inducible expression system for the manufacture of therapeutic proteins from CHO cells.Lead

Innovate UK · Collaborative R&D · 2018-03-01 – 2020-03-31 · with 1 other participant

£72,582

awarded

Synpromics Ltdlead£72,582

Lonza Biologics PLC£65,644

Enhanced Vector Bioprocessing Technologies for Cell and Gene TherapiesLead

Innovate UK · Collaborative R&D · 2016-07-01 – 2019-06-30 · with 1 other participant

£971,427

awarded

Synpromics Limitedlead£971,427

Cell Therapy Catapult Limited£606,297

A toolchest for rapid bootstrapping of novel chassis organisms

Innovate UK · Collaborative R&D · 2014-08-01 – 2015-10-31 · with 2 other participants

£58,819

awarded

Synthace Ltdlead£99,014

Synpromics Limited£58,819

University College London£0

Engineering Promoters for Specific Antigen Expression in a Synthetic DNA Vaccine ConstructLead

Innovate UK · Collaborative R&D · 2014-07-01 – 2015-12-31 · with 1 other participant

£111,896

awarded

Synpromics Limitedlead£111,896

Touchlight Genetics Ltd£95,935

Adaptable Synthetic Promoters to Optimise Industrial Competitiveness of Engineered YeastLead

Innovate UK · Collaborative R&D · 2014-06-01 – 2015-11-30 · with 1 other participant

£150,455

awarded

Synpromics Limitedlead£150,455

Ingenza Limited£139,321

Promoters for Improved Protein & Biopharmaceutics Production in Mammalian CellsLead

Innovate UK · Feasibility Studies · 2013-10-01 – 2015-09-30 · with 2 other participants

£143,533

awarded

Synpromics Limitedlead£143,533

University of Edinburgh£69,524

Genabler Ltd£28,548

Highly-predictive cell-based analysis using biodegradable transfection technology

Innovate UK · Collaborative R&D · 2012-08-01 – 2014-10-31 · with 2 other participants

£34,684

awarded

Avanticell Science Limitedlead£165,340

Deliverics Limited£63,250

Synpromics Limited£34,684